Clinical Approach to Hemoptysis
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of hemoptysis
Hemoptysis, the expectoration of blood originating from the lower respiratory tract, is an alarming symptom that prompts approximately 6.8% of pulmonary outpatient visits and accounts for 15% of pulmonary consultations in hospitalized patients. While the majority of cases (approximately 90%) are mild and self-limiting, massive hemoptysis carries a mortality rate of 50-80% without intervention. In primary care settings, bronchitis and bronchiectasis account for up to 70% of cases, but the symptom demands careful evaluation as lung malignancy is identified in 5-15% of patients presenting with hemoptysis, particularly in those over 40 years of age with a smoking history.
Definition
Hemoptysis is defined as the expectoration of blood or blood-tinged sputum originating from the tracheobronchial tree or pulmonary parenchyma. It must be distinguished from pseudohemoptysis (blood from the upper respiratory tract or gastrointestinal tract that is expectorated) and hematemesis (vomiting of blood from the gastrointestinal tract). True hemoptysis typically produces bright red, frothy blood that is alkaline in pH and mixed with sputum, whereas hematemesis produces dark red or coffee-ground material that is acidic and mixed with food particles.
Classification by Volume
| Category | Volume | Clinical Features | Management Setting |
|---|---|---|---|
| Mild (Trivial) | Less than 20 mL per 24 hours | Blood-streaked sputum, minimal fresh blood, patient hemodynamically stable | Outpatient evaluation appropriate in most cases |
| Moderate | 20 to 200 mL per 24 hours | Noticeable blood production, may cause anxiety, usually stable vital signs | Urgent outpatient or emergency department evaluation |
| Severe (Submassive) | 200 to 600 mL per 24 hours | Significant blood loss, potential for respiratory compromise, may have tachycardia | Hospital admission, pulmonary consultation |
| Massive (Life-Threatening) | Greater than 600 mL per 24 hours OR greater than 100 mL per hour | Risk of asphyxiation, hemodynamic instability, respiratory failure imminent | Intensive care unit, emergent intervention required |
Critical Point: Volume Estimation
Patients typically overestimate the volume of hemoptysis by 2 to 4 times the actual amount. However, it is the rate of bleeding and respiratory reserve that determine clinical severity, not just volume alone. A patient with severe chronic obstructive pulmonary disease may become critically ill from 100 mL of hemoptysis that would be tolerated by a patient with normal lung function. Death from massive hemoptysis is usually due to asphyxiation from airway flooding, not exsanguination.
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 1 week | Acute bronchitis, pneumonia, pulmonary embolism, trauma, foreign body aspiration | Usually self-limiting if due to infection; requires urgent evaluation if massive or associated with chest pain and dyspnea |
| Subacute | 1 to 4 weeks | Resolving infection, early malignancy, bronchiectasis exacerbation, tuberculosis | Warrants imaging and close follow-up; persistence beyond 1 week requires investigation |
| Chronic or Recurrent | Greater than 4 weeks or multiple episodes | Bronchiectasis, lung cancer, chronic infection (tuberculosis, fungal), arteriovenous malformation, mitral stenosis | High suspicion for underlying structural or neoplastic disease; comprehensive workup mandatory |
Classification by Character
Blood-Streaked Sputum
Small amounts of blood mixed with purulent or mucoid sputum. Most commonly associated with acute bronchitis, mild bronchiectasis, or upper respiratory tract infection with vigorous coughing. Generally indicates mucosal inflammation and minor vessel disruption rather than significant parenchymal disease.
Frank Hemoptysis
Pure blood without significant sputum admixture. Raises concern for bronchial artery erosion, cavitary lung disease, malignancy, or vascular anomaly. Requires more urgent evaluation regardless of volume. The bright red, frothy nature indicates arterial origin from the tracheobronchial tree.
Pink Frothy Sputum
Blood-tinged frothy secretions typically indicate pulmonary edema from left heart failure. The pink color results from admixture of small amounts of blood with copious transudative fluid. Associated with dyspnea, orthopnea, and signs of volume overload.
Rust-Colored Sputum
Classically associated with pneumococcal pneumonia. The rusty appearance results from degraded blood mixed with purulent sputum. Also seen in pulmonary infarction and some chronic infections. The color change indicates that blood has been present in the airways for some time.
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Morning predominance | Blood or blood-streaked sputum primarily upon waking | Bronchiectasis (overnight pooling of secretions), chronic bronchitis, lung abscess |
| With vigorous coughing | Blood appears only after paroxysms of cough | Acute bronchitis, upper respiratory infection, bronchial mucosal irritation |
| With exertion | Hemoptysis triggered by physical activity | Mitral stenosis, pulmonary hypertension, arteriovenous malformation |
| Catamenial (menstrual) | Recurring hemoptysis coinciding with menstruation | Thoracic endometriosis (rare but pathognomonic) |
| Sudden onset with chest pain | Acute hemoptysis with pleuritic chest pain | Pulmonary embolism with infarction, pneumonia, pneumothorax |
| Progressive over weeks to months | Gradually increasing frequency or volume | Lung cancer, slowly growing mass, progressive bronchiectasis |
Key Concept: The “Big Four” Causes
Four etiologies account for approximately 80% of all hemoptysis cases:
- Bronchitis (acute and chronic) — Most common cause overall, accounting for 30-50% of cases
- Bronchiectasis — Leading cause of recurrent hemoptysis, responsible for 20-30% of cases
- Lung cancer — Found in 5-15% of patients; higher in smokers over age 40
- Pneumonia and lung abscess — Accounts for 10-20% of cases
However, the prevalence varies significantly by geographic region, with tuberculosis being a leading cause in endemic areas, and by clinical setting (primary care versus tertiary referral center).
Etiology by Clinical Setting
| Setting | Most Common Causes | Important Considerations |
|---|---|---|
| Primary Care / Family Medicine | Acute bronchitis (50%), bronchiectasis (15%), pneumonia (10%) | Most cases are benign and self-limiting; focus on identifying red flags for malignancy or serious disease |
| Pulmonology Referral | Bronchiectasis (25%), lung cancer (20%), bronchitis (15%) | Higher proportion of serious pathology due to referral bias; comprehensive workup indicated |
| Emergency Department | Bronchitis (30%), pneumonia (20%), malignancy (10%), pulmonary embolism (5%) | Must rapidly assess for life-threatening causes; stabilization is priority |
| Tuberculosis Endemic Areas | Tuberculosis (30-50%), bronchiectasis (post-tuberculosis), fungal infection | Maintain high index of suspicion for active tuberculosis; isolation precautions |
Cryptogenic Hemoptysis
In 5-15% of cases, no cause is identified despite thorough investigation—termed cryptogenic or idiopathic hemoptysis. These patients typically have mild, self-limiting bleeding, and prognosis is generally excellent. However, close follow-up is warranted as occult malignancy may be detected on subsequent imaging in up to 6% of initially cryptogenic cases within 3 years.
2. Pathophysiology and Mechanisms
Understanding the vascular anatomy and bleeding mechanisms in hemoptysis
Understanding the dual blood supply to the lungs is fundamental to comprehending hemoptysis. The lungs receive blood from two distinct vascular systems: the pulmonary circulation (a low-pressure system for gas exchange) and the bronchial circulation (a high-pressure system for airway nutrition). The source of bleeding and the underlying mechanism directly influence clinical presentation, severity, and treatment approach.
The Dual Pulmonary Circulation
| Feature | Pulmonary Circulation | Bronchial Circulation |
|---|---|---|
| Origin | Right ventricle via pulmonary arteries | Aorta or intercostal arteries (systemic pressure) |
| Pressure | Low pressure (15-30/8-15 mmHg systolic/diastolic) | High pressure (systemic: 120/80 mmHg) |
| Function | Gas exchange at alveolar-capillary interface | Nutritional supply to airways, bronchi, and supporting structures |
| Percentage of lung blood supply | 99% of total pulmonary blood flow | 1% of total pulmonary blood flow (but can increase 10-fold in disease) |
| Contribution to hemoptysis | 5-10% of cases (usually mild) | 90-95% of cases (including most massive hemoptysis) |
| Typical causes when bleeding | Pulmonary embolism, pulmonary hypertension, vasculitis, arteriovenous malformation | Bronchiectasis, lung cancer, tuberculosis, chronic infection, bronchitis |
Clinical Significance: Although bronchial arteries supply only 1% of pulmonary blood flow, they are the source of 90-95% of hemoptysis cases. In chronic inflammatory conditions like bronchiectasis, bronchial arteries hypertrophy dramatically, increasing blood flow up to 10-fold. These enlarged, tortuous vessels are prone to rupture, resulting in potentially massive arterial bleeding at systemic pressures.
Mechanisms of Bleeding
Inflammatory Mucosal Damage
Conditions: Acute bronchitis, pneumonia, tracheitis
Mechanism: Inflammation causes hyperemia, mucosal friability, and erosion of superficial capillaries. Vigorous coughing further traumatizes the inflamed mucosa.
Bleeding type: Typically mild, self-limiting, blood-streaked sputum
Bronchial Artery Erosion
Conditions: Bronchiectasis, tuberculosis, lung abscess, aspergilloma
Mechanism: Chronic infection leads to bronchial artery hypertrophy, aneurysm formation, and vessel wall weakening. Erosion into a hypertrophied bronchial artery causes arterial bleeding at systemic pressure.
Bleeding type: Can be massive; bright red, profuse
Neovascularization
Conditions: Lung cancer, metastatic disease, chronic inflammation
Mechanism: Tumor angiogenesis creates fragile, abnormal vessels lacking normal architecture. These vessels are susceptible to spontaneous rupture and do not respond normally to hemostatic mechanisms.
Bleeding type: Variable; may be recurrent and progressive
Pulmonary Vascular Injury
Conditions: Pulmonary embolism, vasculitis, diffuse alveolar hemorrhage
Mechanism: Embolism causes infarction with hemorrhage into alveoli. Vasculitis damages vessel walls directly. Autoimmune conditions cause capillaritis with diffuse hemorrhage.
Bleeding type: Mild hemoptysis with PE; may be diffuse and bilateral in vasculitis
Pulmonary Venous Hypertension
Conditions: Mitral stenosis, left heart failure, pulmonary veno-occlusive disease
Mechanism: Elevated left atrial pressure transmits to pulmonary veins, causing venous congestion, capillary distension, and eventual rupture of distended bronchial veins (which drain into pulmonary veins).
Bleeding type: Pink frothy sputum; rarely massive
Direct Vascular Communication
Conditions: Arteriovenous malformation, aortobronchial fistula (rare)
Mechanism: Abnormal direct connections between arterial and venous systems or between aorta and bronchial tree. High-flow shunts may rupture; fistulas cause catastrophic hemorrhage.
Bleeding type: Can be sudden and massive
How Specific Conditions Cause Hemoptysis
| Condition | Primary Mechanism | Treatment Implication |
|---|---|---|
| Acute bronchitis | Viral or bacterial inflammation causes mucosal hyperemia and erosion; forceful coughing traumatizes friable mucosa | Self-limiting; supportive care with cough suppression; antibiotics only if bacterial superinfection |
| Bronchiectasis | Chronic infection leads to bronchial artery hypertrophy (up to 300% normal diameter), tortuosity, and aneurysm formation; vessels erode into airway lumen | Bronchial artery embolization for significant bleeding; long-term airway clearance and infection control |
| Lung cancer | Tumor neovascularization creates fragile vessels; direct invasion erodes into bronchial or pulmonary vessels; central tumors may erode major airways | May require bronchial artery embolization, radiation therapy, or surgical resection; palliative measures if advanced |
| Tuberculosis | Cavity formation with bronchial artery hypertrophy; Rasmussen aneurysm (pulmonary artery pseudoaneurysm eroding into cavity); erosion into major vessels | Antituberculous therapy essential; embolization or surgery for massive bleeding; Rasmussen aneurysm is surgical emergency |
| Pulmonary aspergilloma | Fungus ball (mycetoma) in pre-existing cavity causes mechanical irritation and releases angiogenic factors; surrounding bronchial arteries hypertrophy and rupture | Surgical resection if feasible; bronchial artery embolization for bleeding; antifungal therapy has limited efficacy |
| Pulmonary embolism | Pulmonary infarction (occurs in approximately 10% of PE) causes hemorrhage into alveolar space; typically involves peripheral lung tissue | Anticoagulation is treatment of choice; hemoptysis is typically mild and self-limiting despite anticoagulation |
| Mitral stenosis | Elevated left atrial pressure causes pulmonary venous hypertension; rupture of distended submucosal bronchial veins; rarely due to pulmonary artery rupture from severe pulmonary hypertension | Optimize cardiac management; diuresis; valve intervention for severe stenosis; hemoptysis may indicate need for surgical correction |
| Diffuse alveolar hemorrhage | Capillaritis from vasculitis (granulomatosis with polyangiitis, Goodpasture syndrome) causes widespread capillary damage; blood accumulates in alveolar spaces | Immunosuppression is cornerstone; plasmapheresis for anti-glomerular basement membrane disease; may require mechanical ventilation |
| Pneumonia | Intense inflammation with mucosal hyperemia; necrosis of lung tissue (necrotizing pneumonia); lung abscess formation with erosion into vessels | Appropriate antimicrobial therapy; drainage if abscess present; embolization rarely needed |
| Arteriovenous malformation | Direct communication between pulmonary artery and vein; thin-walled abnormal vessels prone to rupture, especially during pregnancy or with pulmonary hypertension | Embolization or surgical resection; screen for hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) |
Bronchial Artery Anatomy and Variants
Clinically Important Anatomical Points
Understanding bronchial artery anatomy is essential for interventional radiology and surgical planning:
- Origin: Most bronchial arteries arise from the descending thoracic aorta between T5 and T6 vertebral levels (within 1 cm above or below the left main bronchus)
- Common pattern (40%): One right bronchial artery arising from a common trunk with an intercostal artery (intercostobronchial trunk) and two left bronchial arteries
- Variant origins (20-30%): Bronchial arteries may arise from the aortic arch, subclavian arteries, internal mammary arteries, or aberrant locations—missed variant vessels are a common cause of failed embolization
- Spinal artery anastomosis: The anterior spinal artery (artery of Adamkiewicz) may share origin with bronchial arteries in up to 5% of patients—inadvertent embolization can cause paraplegia
Natural History: Why Bleeding Stops and Recurs
Why Bleeding Typically Stops
- Hypotension: Blood loss reduces systemic pressure, decreasing bronchial artery perfusion pressure
- Clot formation: Normal hemostatic mechanisms form clot at bleeding site
- Vasospasm: Local vasoconstriction reduces blood flow to injured area
- Tamponade effect: Blood in airways creates back-pressure against bleeding vessel
- Cough suppression: Less mechanical trauma to injured mucosa
Why Bleeding Recurs
- Clot dislodgement: Coughing or suctioning removes protective clot
- Resumption of normal blood pressure: Resuscitation restores perfusion pressure
- Continued inflammation: Ongoing disease process maintains vessel friability
- Collateral vessel formation: After embolization, collaterals may recruit and bleed
- Disease progression: Tumor growth, cavity enlargement, or infection spread
Often Overlooked: Non-Bronchopulmonary Sources
Pseudohemoptysis accounts for up to 15% of patients presenting with apparent hemoptysis. Blood originating from the nasopharynx, oropharynx, or gastrointestinal tract may be expectorated and misinterpreted as true hemoptysis. Key clues include:
- Epistaxis: Blood dripping posteriorly from nasal cavity, especially at night
- Gingival bleeding: Periodontal disease, anticoagulation, or recent dental procedures
- Hematemesis with aspiration: Dark blood, acidic pH, mixed with food particles, history of gastrointestinal disease
- Oropharyngeal lesion: Pharyngeal cancer, severe pharyngitis
Always examine the nose, mouth, and oropharynx carefully in any patient presenting with hemoptysis, particularly if chest imaging is normal.
Role of Coagulation Status
| Coagulation Abnormality | Effect on Hemoptysis | Clinical Approach |
|---|---|---|
| Therapeutic anticoagulation | Does not typically initiate bleeding but may prolong or worsen hemoptysis from an underlying lesion | Search for underlying cause; reversal may be needed for severe bleeding but anticoagulation often continued for minor hemoptysis |
| Thrombocytopenia | Increases bleeding risk if platelet count below 50,000/μL; severe risk below 20,000/μL | Platelet transfusion for active bleeding; investigate cause of thrombocytopenia |
| Liver disease with coagulopathy | Impaired synthesis of clotting factors prolongs bleeding time | Fresh frozen plasma and vitamin K; address underlying hepatic dysfunction |
| Disseminated intravascular coagulation | May cause diffuse alveolar hemorrhage as part of multiorgan involvement | Treat underlying trigger; supportive care; may be refractory to hemostatic measures |
3. History Taking
A comprehensive approach to eliciting the hemoptysis history
Red Flags — Require Urgent Evaluation
- Massive hemoptysis (greater than 100 mL/hour or 600 mL/24 hours) — Risk of asphyxiation, requires emergent intervention
- Respiratory distress or hypoxemia — Suggests significant blood in airways or underlying severe lung disease
- Hemodynamic instability — Indicates substantial blood loss or cardiovascular compromise
- Age greater than 40 years with smoking history — Significantly increased lung cancer risk
- Unexplained weight loss (greater than 5% body weight) — Suggests malignancy or chronic infection (tuberculosis)
- Known or suspected malignancy — May indicate tumor progression or erosion into vessels
- Recurrent hemoptysis without clear cause — Requires thorough investigation for occult pathology
- Associated hematuria or renal dysfunction — Suggests pulmonary-renal syndrome (vasculitis, Goodpasture syndrome)
Systematic History: The “BLOOD” Approach
Use the mnemonic “BLOOD” to ensure comprehensive history taking for hemoptysis:
- B — Bleeding characteristics: Volume (teaspoons, tablespoons, cups), color (bright red, dark, pink frothy, rust), consistency (pure blood, blood-streaked sputum, clots), frequency, and duration
- L — Localizing symptoms: Can the patient identify which side the blood is coming from? Unilateral chest pain or gurgling sensation may localize the source. Also assess for alternative sources (epistaxis, gum bleeding, hematemesis)
- O — Other associated symptoms: Cough (acute, chronic, character), dyspnea, chest pain (pleuritic or dull), fever, night sweats, weight loss, leg swelling or pain, palpitations
- O — Occupational, social, and exposure history: Smoking (pack-years), occupational exposures (asbestos, silica, coal), travel history (tuberculosis-endemic areas), illicit drug use (crack cocaine), immunosuppression
- D — Drug and past medical history: Anticoagulants, antiplatelet agents, prior lung disease, tuberculosis exposure or treatment, cardiac disease, bleeding disorders, previous hemoptysis episodes and their workup
Step 1: Confirm True Hemoptysis
| Feature | True Hemoptysis | Hematemesis | Pseudohemoptysis (Upper Airway) |
|---|---|---|---|
| History | Preceded by cough, tickling sensation in chest | Preceded by nausea, retching, abdominal pain | May notice blood in nose, throat, or on pillow |
| Appearance | Bright red, frothy, mixed with sputum | Dark red or coffee-ground, mixed with food | Bright red, may be mixed with nasal secretions |
| pH | Alkaline | Acidic | Neutral to alkaline |
| Associated symptoms | Cough, dyspnea, chest pain | Melena, history of liver disease or peptic ulcer | Nasal congestion, sore throat, epistaxis |
| Key question | “Did you cough it up?” | “Did you vomit it up?” | “Did you notice blood dripping from your nose or in your throat?” |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Acute bronchitis | Recent upper respiratory infection, productive cough, blood-streaked sputum | “Did you have a cold or sore throat before this started? Has the cough been getting worse?” |
| Bronchiectasis | Chronic productive cough, recurrent respiratory infections, morning sputum production | “Do you cough up large amounts of sputum, especially in the morning? Have you had many chest infections over the years?” |
| Lung cancer | Smoking history, weight loss, chronic cough, hoarseness, bone pain | “How many years have you smoked and how many cigarettes per day? Have you noticed any weight loss or change in your voice?” |
| Tuberculosis | Night sweats, weight loss, fever, exposure history, endemic area travel or residence | “Have you had fevers, night sweats, or unintentional weight loss? Have you been in contact with anyone with tuberculosis or traveled to areas where tuberculosis is common?” |
| Pulmonary embolism | Sudden onset dyspnea, pleuritic chest pain, leg swelling, immobility, recent surgery | “Did the hemoptysis start suddenly with sharp chest pain or shortness of breath? Have you had any recent surgery, long flights, or leg swelling?” |
| Pneumonia | Fever, productive cough (rust-colored or purulent), pleuritic pain, rigors | “Do you have a fever or chills? Is the sputum a different color like yellow, green, or rust-colored?” |
| Heart failure with pulmonary edema | Orthopnea, paroxysmal nocturnal dyspnea, leg edema, pink frothy sputum | “Do you wake up at night gasping for air? How many pillows do you sleep on? Have you noticed swelling in your ankles?” |
| Mitral stenosis | History of rheumatic fever, atrial fibrillation, exertional dyspnea, hemoptysis with exertion | “Did you have rheumatic fever as a child? Does your heart ever race or beat irregularly? Do you get short of breath with exercise?” |
| Vasculitis (granulomatosis with polyangiitis) | Sinus symptoms, bloody nasal discharge, joint pain, hematuria, skin lesions | “Do you have any sinus problems, nose bleeds, or blood in your urine? Have you noticed a rash or joint pain?” |
| Goodpasture syndrome | Young male smoker, hemoptysis with hematuria and renal dysfunction | “Have you noticed any blood in your urine or changes in your urine output? Has anyone mentioned that your kidney function is abnormal?” |
| Pulmonary arteriovenous malformation | Recurrent epistaxis, family history of hereditary hemorrhagic telangiectasia, telangiectasias on skin or mucosa | “Do you get frequent nosebleeds? Does anyone in your family have a bleeding disorder or telangiectasias (small red spots on the skin or lips)?” |
| Aspergilloma | Previous tuberculosis or lung cavity, chronic cough, recurrent hemoptysis | “Have you ever had tuberculosis or been told you have a cavity or scar in your lung?” |
Quantifying Blood Volume
Practical Volume Estimation
Patients often overestimate hemoptysis volume by 2-4 times. Use these practical references to help quantify:
- Teaspoon: Approximately 5 mL
- Tablespoon: Approximately 15 mL
- Shot glass: Approximately 30 mL
- Quarter cup: Approximately 60 mL
- Half cup: Approximately 120 mL
- Full cup: Approximately 240 mL
Ask: “If you collected all the blood you coughed up in a container, how much would there be—a teaspoon, a tablespoon, a shot glass, or more?”
Medication and Drug History
Medications That Increase Bleeding Risk
- Anticoagulants (warfarin, heparin, direct oral anticoagulants) — Do not cause hemoptysis but prolong and worsen bleeding from underlying lesions
- Antiplatelet agents (aspirin, clopidogrel) — Impair platelet function and hemostasis
- Nonsteroidal anti-inflammatory drugs — Antiplatelet effect and potential for gastrointestinal bleeding (hematemesis misdiagnosed as hemoptysis)
- Thrombolytics — Recent use may cause or exacerbate pulmonary hemorrhage
- Bevacizumab and other anti-angiogenic agents — Associated with increased hemoptysis risk, particularly in patients with squamous cell lung cancer
Drugs and Exposures Causing Pulmonary Disease
- Crack cocaine — Diffuse alveolar hemorrhage (“crack lung”), pulmonary infarction
- Inhaled drugs — Thermal and chemical airway injury
- Amiodarone — Pulmonary toxicity with potential hemorrhage
- Methotrexate, bleomycin, nitrofurantoin — Drug-induced lung disease
- Penicillamine — Associated with diffuse alveolar hemorrhage
Social and Occupational History
| Factor | Relevant Exposures | Associated Conditions |
|---|---|---|
| Smoking | Calculate pack-years (packs per day × years smoked); include prior smoking history | Lung cancer (risk increases with pack-years), chronic bronchitis, emphysema |
| Occupational exposures | Asbestos (shipyard, construction, insulation), silica (mining, sandblasting), coal dust | Lung cancer, mesothelioma, silicosis, coal workers’ pneumoconiosis |
| Travel history | Travel to or residence in tuberculosis-endemic areas (Southeast Asia, Africa, South America, Eastern Europe) | Tuberculosis, parasitic infections (paragonimiasis, hydatid cyst) |
| Immigration status | Country of origin, time since immigration | Tuberculosis (may reactivate years after immigration) |
| Illicit drug use | Crack cocaine, intravenous drug use | Diffuse alveolar hemorrhage, septic pulmonary emboli (from endocarditis) |
| Sexual history | Immunosuppression risk (HIV) | Kaposi sarcoma, opportunistic infections, tuberculosis |
| Incarceration history | Congregate settings with tuberculosis exposure | Tuberculosis (higher prevalence in prison populations) |
Relevant Past Medical History
Pulmonary Conditions
- Previous tuberculosis (risk of aspergilloma, bronchiectasis)
- Bronchiectasis (leading cause of recurrent hemoptysis)
- Chronic obstructive pulmonary disease
- Interstitial lung disease
- Prior lung cancer or other thoracic malignancy
- Cystic fibrosis
- Previous pulmonary embolism
Cardiovascular and Systemic Conditions
- Mitral valve disease (stenosis, especially from rheumatic heart disease)
- Congestive heart failure
- Atrial fibrillation (with anticoagulation)
- Deep vein thrombosis history
- Autoimmune disease (systemic lupus erythematosus, vasculitis)
- Bleeding disorders
- Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)
Don’t Forget Family History
Family history can provide important diagnostic clues:
- Hereditary hemorrhagic telangiectasia: Autosomal dominant; ask about recurrent epistaxis, telangiectasias, and similar bleeding in family members
- Cystic fibrosis: Autosomal recessive; ask about family members with chronic lung disease or pancreatic insufficiency
- Alpha-1 antitrypsin deficiency: Early-onset emphysema in non-smokers
- Lung cancer: Increased risk with family history, especially in non-smokers
- Bleeding disorders: Hemophilia, von Willebrand disease
4. Physical Examination
A systematic head-to-toe approach for hemoptysis
Systematic Framework: Use the “Assess, Airway, then Head to Extremities” approach for complete examination of patients presenting with hemoptysis. Begin with a rapid assessment of hemodynamic stability and airway compromise, then proceed systematically to identify the source and underlying cause.
Initial Rapid Assessment
Assess for Life-Threatening Presentation
Before proceeding with detailed examination, rapidly assess for:
- Airway patency: Can the patient speak in full sentences? Is there stridor or gurgling?
- Respiratory distress: Accessory muscle use, tripod positioning, cyanosis, oxygen saturation
- Hemodynamic stability: Blood pressure, heart rate, signs of shock (pallor, diaphoresis, altered mental status)
- Ongoing active bleeding: Is the patient actively coughing up blood during the examination?
If any of these are present, stabilization takes priority over detailed examination.
General Inspection
- Appearance: Well or unwell, anxious, cachexia (malignancy, tuberculosis, chronic disease), cushingoid features (chronic steroid use)
- Respiratory effort: Tachypnea, use of accessory muscles, intercostal retractions, pursed-lip breathing
- Color: Pallor (anemia from chronic blood loss), cyanosis (hypoxemia), plethora (polycythemia)
- Cough character: If patient coughs during examination, observe sputum—color, volume, presence of blood
- Voice: Hoarseness may indicate laryngeal involvement (tumor, recurrent laryngeal nerve compression)
- Hydration status: Mucous membranes, skin turgor
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever (greater than 38°C) | Suggests infection (pneumonia, tuberculosis, lung abscess); low-grade fever may occur with malignancy |
| Heart Rate | Tachycardia (greater than 100 beats per minute) | May indicate significant blood loss, fever, pain, anxiety, or underlying cardiac disease; irregularly irregular suggests atrial fibrillation |
| Blood Pressure | Hypotension or orthostatic changes | Suggests significant blood loss or sepsis; hypertension may indicate pulmonary-renal syndrome |
| Respiratory Rate | Tachypnea (greater than 20 breaths per minute) | Indicates respiratory compromise, blood in airways, underlying lung disease, or metabolic compensation |
| Oxygen Saturation | Hypoxemia (less than 94% on room air) | Suggests significant lung pathology, blood in airways, or underlying chronic lung disease; does not correlate with hemoptysis volume |
Head, Eyes, Ears, Nose, and Throat Examination
Nose and Nasopharynx
Purpose: Exclude pseudohemoptysis from nasal source
- Anterior rhinoscopy for mucosal lesions, polyps, or active bleeding
- Septal perforation (cocaine use, granulomatosis with polyangiitis)
- Crusting or granulation (vasculitis)
- Evidence of posterior epistaxis (blood tracking down posterior pharynx)
Oropharynx
Purpose: Exclude oral or pharyngeal bleeding source
- Gingival bleeding or periodontal disease
- Pharyngeal lesions or masses
- Telangiectasias on lips, tongue, or buccal mucosa (hereditary hemorrhagic telangiectasia)
- Tonsillar lesions
Eyes
- Conjunctival pallor (anemia)
- Scleral icterus (liver disease with coagulopathy)
- Telangiectasias on conjunctiva (hereditary hemorrhagic telangiectasia)
Ears
- Hearing loss (granulomatosis with polyangiitis can cause sensorineural hearing loss)
Neck Examination
- Lymphadenopathy: Cervical or supraclavicular nodes may indicate malignancy (especially left supraclavicular “Virchow’s node”), tuberculosis, or lymphoma
- Tracheal position: Deviation suggests large pleural effusion, pneumothorax, or mediastinal mass
- Thyroid: Enlargement may cause tracheal compression; thyroid malignancy can metastasize to lungs
- Jugular venous pressure: Elevation suggests right heart failure, pulmonary hypertension, or superior vena cava obstruction
- Stridor: Inspiratory noise indicates upper airway obstruction (tumor, foreign body, blood clot)
Respiratory Examination
Inspection
- Chest wall deformity: Kyphoscoliosis, pectus excavatum (may affect lung function)
- Surgical scars: Previous thoracic surgery, chest tube sites
- Asymmetric expansion: Reduced on side of pathology (effusion, collapse, fibrosis)
- Visible masses: Chest wall invasion by tumor
- Radiation changes: Skin changes from previous radiation therapy
Palpation
- Chest expansion: Asymmetric expansion localizes pathology; reduced bilaterally in hyperinflation
- Tactile fremitus: Increased over consolidation, decreased over effusion or pneumothorax
- Tenderness: Chest wall tenderness (rib metastases, fracture from coughing)
- Subcutaneous emphysema: Crepitus suggests pneumothorax with air tracking into soft tissues
Percussion
- Dullness: Suggests consolidation (pneumonia, mass), pleural effusion, or hemothorax
- Hyperresonance: Suggests pneumothorax or hyperinflation (emphysema)
- Asymmetry: Compare systematically between right and left sides
Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Bronchial breath sounds | Loud, hollow, high-pitched with equal inspiratory and expiratory phases | Consolidation (pneumonia, lung collapse with patent airway) |
| Diminished breath sounds | Reduced or absent air entry | Pleural effusion, pneumothorax, complete airway obstruction, severe hyperinflation |
| Crackles (rales) | Fine: Velcro-like, end-inspiratory; Coarse: early inspiratory, may clear with cough | Fine: interstitial lung disease, early pulmonary edema; Coarse: bronchiectasis, pneumonia, pulmonary edema |
| Wheezes | Polyphonic: multiple pitches, diffuse; Monophonic: single fixed pitch, localized | Polyphonic: asthma, COPD, heart failure; Monophonic: focal obstruction (tumor, foreign body, blood clot) |
| Pleural friction rub | Creaking or grating sound, heard in both phases of respiration | Pleuritis (pulmonary embolism with infarction, pneumonia, malignancy) |
| Stridor | High-pitched inspiratory sound, often audible without stethoscope | Upper airway obstruction (tumor, blood clot, foreign body) |
Cardiovascular Examination
| Finding | How to Assess | Significance |
|---|---|---|
| Elevated jugular venous pressure | Assess at 45 degrees; measure height above sternal angle | Right heart failure, pulmonary hypertension, pericardial disease, superior vena cava syndrome |
| Displaced apex beat | Palpate in left lateral position; normally in 5th intercostal space, midclavicular line | Cardiomegaly (heart failure), mediastinal shift |
| Right ventricular heave | Parasternal lift palpated at left sternal edge | Right ventricular hypertrophy from pulmonary hypertension |
| Loud P2 | Increased intensity of pulmonary component of second heart sound | Pulmonary hypertension |
| Murmurs | Low-pitched diastolic rumble at apex (mitral stenosis); pansystolic at apex (mitral regurgitation) | Mitral stenosis is a classic cause of hemoptysis; mitral regurgitation suggests heart failure |
| Irregularly irregular rhythm | Auscultate at apex while palpating radial pulse | Atrial fibrillation (associated with mitral stenosis; patient likely on anticoagulation) |
| S3 gallop | Low-frequency sound in early diastole, best heard with bell at apex | Left ventricular failure, volume overload |
Abdominal Examination
- Hepatomegaly: May indicate right heart failure, liver metastases, or primary liver disease with coagulopathy
- Splenomegaly: May suggest hematologic malignancy, portal hypertension
- Ascites: Liver disease (with coagulopathy), right heart failure, malignancy
- Epigastric tenderness: Consider hematemesis masquerading as hemoptysis
Extremities
| Finding | Description | Significance |
|---|---|---|
| Clubbing | Loss of nail bed angle (Lovibond angle greater than 180°), increased nail bed fluctuation, drumstick appearance | Lung cancer, bronchiectasis, interstitial lung disease, cyanotic heart disease, lung abscess, empyema |
| Cyanosis | Bluish discoloration of nail beds and lips | Hypoxemia, right-to-left shunt (pulmonary arteriovenous malformation) |
| Peripheral edema | Pitting edema of ankles and legs | Right heart failure, cor pulmonale from chronic lung disease |
| Unilateral leg swelling | Asymmetric swelling with tenderness, warmth, or cord | Deep vein thrombosis (source of pulmonary embolism) |
| Telangiectasias | Small red vascular lesions on fingertips, nail beds | Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) |
| Nicotine staining | Yellow-brown staining of fingers | Heavy smoking history (risk factor for lung cancer, chronic bronchitis) |
Skin Examination
- Telangiectasias: On face, lips, tongue, fingertips (hereditary hemorrhagic telangiectasia)
- Bruising: Easy bruising suggests bleeding disorder or anticoagulation
- Palpable purpura: Vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis)
- Kaposi sarcoma lesions: Purple-red nodules in immunocompromised patients
- Erythema nodosum: Tender red nodules on shins (sarcoidosis, tuberculosis, inflammatory bowel disease)
Expected Findings by Etiology
| Condition | General Appearance | Respiratory Findings | Other Key Findings |
|---|---|---|---|
| Acute bronchitis | Generally well, may appear uncomfortable | Usually normal; may have scattered rhonchi | Low-grade fever, upper respiratory symptoms |
| Bronchiectasis | May have chronic illness appearance; clubbing in advanced cases | Coarse crackles, often localized to affected area | Clubbing, productive cough during examination |
| Lung cancer | Weight loss, cachexia; may appear well in early disease | May be normal; localized wheeze, decreased breath sounds, dullness if effusion | Clubbing, lymphadenopathy (supraclavicular), Horner syndrome, hoarseness |
| Tuberculosis | Cachexia, night sweats, fever | Often upper lobe findings; crackles, bronchial breathing over cavity | Lymphadenopathy (cervical), erythema nodosum |
| Pulmonary embolism | Anxious, tachypneic | Often normal; may have pleural rub, decreased breath sounds | Unilateral leg swelling, tachycardia, low-grade fever |
| Heart failure | Dyspneic, orthopnea | Bilateral fine crackles, especially at bases | Elevated JVP, peripheral edema, S3 gallop, displaced apex |
| Mitral stenosis | May have malar flush | May have crackles from pulmonary congestion | Low-pitched diastolic rumble at apex, atrial fibrillation, loud S1 |
| Vasculitis | Systemic illness appearance | May have diffuse crackles (alveolar hemorrhage) | Palpable purpura, nasal crusting, arthritis, hematuria |
Important Teaching Point
Normal examination is common! Many causes of hemoptysis present with entirely normal physical examination findings. Acute bronchitis, early-stage lung cancer, small pulmonary embolism, and mild bronchiectasis often have no abnormal findings on examination. A normal examination does not exclude significant pathology and should not provide false reassurance. The history, risk factors, and appropriate investigations guide further workup regardless of examination findings.
Clinical Pearl: Localizing the Bleeding Side
Ask the patient if they can identify which side the blood is coming from. Patients can sometimes localize the bleeding based on:
- A sensation of warmth or gurgling on one side
- Unilateral chest discomfort preceding hemoptysis
- Lying on one side stops or increases bleeding
This information can be valuable for positioning the patient (bleeding side down to protect the non-bleeding lung) and guiding bronchoscopy. However, patient localization is not always reliable and should be correlated with imaging.
5. Differential Diagnosis
Systematic approach organized by probability, duration, and clinical features
Acute Hemoptysis (Duration: Less Than 1 Week)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 60-70%) | Acute bronchitis | Preceding upper respiratory infection, productive cough, blood-streaked sputum, low-grade fever | Hemoptysis persisting beyond 1 week; recurrence after resolution |
| COMMON | Community-acquired pneumonia | Fever, productive cough (rust-colored or purulent), pleuritic chest pain, consolidation on examination | Hemoptysis with sepsis, cavitation on imaging, immunocompromised host |
| COMMON | Acute exacerbation of bronchiectasis | Known bronchiectasis, increased sputum volume and purulence, chronic productive cough | Large-volume hemoptysis, hemodynamic instability |
| LESS COMMON (approximately 15-25%) | Pulmonary embolism with infarction | Sudden dyspnea, pleuritic chest pain, risk factors (immobility, malignancy, recent surgery), hemoptysis typically mild | Hypoxemia, hemodynamic instability, syncope |
| LESS COMMON | Acute exacerbation of chronic obstructive pulmonary disease | Known COPD, increased dyspnea and cough, blood-streaked sputum from mucosal irritation | New hemoptysis in COPD patient warrants malignancy workup |
| UNCOMMON BUT SERIOUS (approximately 5-10%) | Lung cancer (presenting symptom) | Smoker over age 40, weight loss, hoarseness, persistent cough, may be first presentation | Any hemoptysis in high-risk patient requires urgent imaging |
| UNCOMMON BUT SERIOUS | Diffuse alveolar hemorrhage | Bilateral infiltrates, dropping hemoglobin, associated renal dysfunction, vasculitis symptoms | Rapidly progressive dyspnea, hemoptysis may be absent initially despite significant hemorrhage |
| UNCOMMON BUT SERIOUS | Foreign body aspiration | Choking episode, localized wheeze, recurrent pneumonia in same location | Respiratory distress, inability to clear secretions |
Chronic or Recurrent Hemoptysis (Duration: Greater Than 4 Weeks or Multiple Episodes)
Step-by-Step Approach to Chronic Hemoptysis:
- Step 1: Exclude malignancy — Chest imaging (CT) is mandatory in all patients with chronic hemoptysis, especially smokers over age 40
- Step 2: Consider the “Big Four” causes — Bronchiectasis, lung cancer, chronic bronchitis, tuberculosis (in endemic areas)
- Step 3: Evaluate for cardiac causes — Mitral stenosis, heart failure, pulmonary hypertension
- Step 4: Investigate for less common causes if initial workup is negative — Arteriovenous malformation, aspergilloma, vasculitis
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Bronchiectasis | 20-30% of chronic hemoptysis | Chronic productive cough, recurrent respiratory infections, daily sputum production, childhood respiratory illness or tuberculosis history |
| COMMON | Chronic bronchitis | 15-25% | Smoking history, productive cough for at least 3 months per year for 2 consecutive years, blood-streaking during exacerbations |
| COMMON | Lung cancer | 10-20% (higher in referral centers) | Smoking history, age over 40, weight loss, persistent cough, hoarseness, bone pain, clubbing |
| COMMON (endemic areas) | Tuberculosis (active or sequelae) | 10-30% in endemic regions | Night sweats, weight loss, fever, exposure history, upper lobe disease, cavitation |
| LESS COMMON | Aspergilloma (mycetoma) | 5-10% | Pre-existing lung cavity (from tuberculosis, sarcoidosis), recurrent hemoptysis, “fungus ball” on imaging |
| LESS COMMON | Mitral stenosis | Less than 5% (decreasing in developed countries) | History of rheumatic fever, exertional dyspnea, atrial fibrillation, diastolic murmur |
| LESS COMMON | Pulmonary arteriovenous malformation | Less than 5% | Hereditary hemorrhagic telangiectasia (epistaxis, telangiectasias), hypoxemia, clubbing, paradoxical emboli |
| UNCOMMON | Idiopathic pulmonary hemosiderosis | Rare | Recurrent hemoptysis, iron deficiency anemia, diffuse infiltrates, no identifiable cause |
| UNCOMMON | Pulmonary endometriosis (catamenial hemoptysis) | Rare | Hemoptysis coinciding with menstruation, otherwise healthy young woman |
Anatomical Approach to Differential Diagnosis
Upper Airways (Pseudohemoptysis)
Epistaxis (posterior)
Oropharyngeal bleeding
Laryngeal carcinoma
Gingival disease
Tracheobronchial Tree
Acute and chronic bronchitis
Bronchiectasis
Bronchogenic carcinoma
Carcinoid tumor
Foreign body
Pulmonary Parenchyma
Pneumonia and lung abscess
Tuberculosis
Aspergilloma
Pulmonary infarction
Diffuse alveolar hemorrhage
Granulomatosis with polyangiitis
Pulmonary Vasculature and Heart
Pulmonary embolism
Arteriovenous malformation
Mitral stenosis
Left ventricular failure
Pulmonary hypertension
Drug-Induced Hemoptysis
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Anticoagulants (warfarin, heparin, direct oral anticoagulants) | Do not initiate bleeding but prolong and worsen hemorrhage from underlying lesion | Hemoptysis often unmasks occult pathology; always investigate for underlying cause | Investigate underlying cause; consider reversal for life-threatening bleeding; often can continue anticoagulation for minor hemoptysis |
| Antiplatelet agents (aspirin, clopidogrel, prasugrel) | Impair platelet aggregation; prolong bleeding time | Similar to anticoagulants; exacerbates bleeding from mucosal lesions | Platelet transfusion if severe; hold if possible; investigate underlying cause |
| Bevacizumab (anti-vascular endothelial growth factor) | Impairs vascular healing and angiogenesis; causes vessel fragility | Increased risk of fatal hemoptysis in squamous cell lung cancer (up to 30%); contraindicated in this population | Discontinue therapy; supportive care; high mortality |
| Crack cocaine | Thermal injury to airways; diffuse alveolar damage; pulmonary infarction from vasoconstriction | Acute onset after use; may cause diffuse alveolar hemorrhage (“crack lung”); associated with pneumothorax | Supportive care; cessation of use; may require mechanical ventilation |
| Penicillamine | Drug-induced pulmonary-renal syndrome; anti-glomerular basement membrane-like antibodies | Diffuse alveolar hemorrhage with glomerulonephritis; resembles Goodpasture syndrome | Discontinue drug; immunosuppression; plasmapheresis |
| Amiodarone | Drug-induced pulmonary toxicity with potential for hemorrhage | Usually presents with dyspnea and infiltrates; hemoptysis less common but reported | Discontinue if possible; corticosteroids for pulmonary toxicity |
| Sirolimus (rapamycin) | Alveolar hemorrhage reported, especially in lung transplant recipients | May present with dyspnea, cough, and hemoptysis; diffuse infiltrates | Dose reduction or discontinuation; exclude infection |
Differential Diagnosis by Severity
| Severity | Most Likely Causes | Clinical Approach |
|---|---|---|
| Blood-streaked sputum (mild) | Acute bronchitis (most common), upper respiratory infection, chronic bronchitis exacerbation, mild bronchiectasis | Outpatient evaluation if no red flags; chest radiograph; follow-up in 1-2 weeks if symptoms persist |
| Moderate hemoptysis (20-200 mL/day) | Bronchiectasis, lung cancer, pneumonia, tuberculosis, pulmonary embolism | Urgent evaluation with CT chest; consider bronchoscopy; hospital admission for observation in most cases |
| Massive hemoptysis (greater than 600 mL/day) | Bronchiectasis (most common cause of massive hemoptysis), tuberculosis, aspergilloma, lung cancer, arteriovenous malformation | Emergent stabilization; ICU admission; bronchoscopy and/or CT angiography; bronchial artery embolization or surgery |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Blood-streaked sputum after upper respiratory infection | Acute bronchitis | Supportive care; chest radiograph if persists beyond 1 week or recurs |
| Smoker over 40 with new hemoptysis | Lung cancer until proven otherwise | CT chest; bronchoscopy if CT abnormal or high suspicion |
| Chronic productive cough with recurrent hemoptysis | Bronchiectasis | High-resolution CT chest; sputum culture |
| Night sweats, weight loss, fever, endemic area exposure | Tuberculosis | Isolation; sputum for acid-fast bacilli smear and culture; chest radiograph |
| Sudden dyspnea, pleuritic chest pain, risk factors for venous thromboembolism | Pulmonary embolism | CT pulmonary angiography; D-dimer if low probability |
| Hemoptysis with hematuria and renal dysfunction | Pulmonary-renal syndrome (granulomatosis with polyangiitis, Goodpasture syndrome) | Urgent renal function, urinalysis, ANCA, anti-GBM antibodies; nephrology and pulmonology consultation |
| Recurrent epistaxis, telangiectasias, family history | Hereditary hemorrhagic telangiectasia with pulmonary arteriovenous malformation | Contrast echocardiography (bubble study); CT chest with contrast |
| Hemoptysis in patient with previous tuberculosis or lung cavity | Aspergilloma | CT chest (look for intracavitary mass); Aspergillus serology |
| Pink frothy sputum with orthopnea and leg edema | Acute pulmonary edema (left heart failure) | Urgent diuresis; echocardiography; treat underlying cardiac condition |
| Hemoptysis with diastolic murmur and atrial fibrillation | Mitral stenosis | Echocardiography; cardiology consultation for valve intervention |
| Young woman with hemoptysis coinciding with menstruation | Catamenial hemoptysis (pulmonary endometriosis) | Document temporal relationship; CT chest; consider hormonal suppression or thoracoscopy |
Cryptogenic (Idiopathic) Hemoptysis
In 5-15% of cases, no cause is identified despite thorough evaluation including CT and bronchoscopy—termed cryptogenic hemoptysis. Key points:
- More common with mild hemoptysis and in younger, non-smoking patients
- Prognosis is generally excellent with low recurrence rates
- However, up to 6% may be diagnosed with malignancy on follow-up imaging within 3 years
- Recommend follow-up chest imaging at 6-12 months, earlier if symptoms recur
- Smoking cessation counseling remains important
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Chest radiograph (posteroanterior and lateral) | First-line imaging; identify masses, infiltrates, cavities, cardiomegaly | Mass or nodule, consolidation, cavity, hilar enlargement, effusion, cardiomegaly | Normal in up to 30% of patients with hemoptysis; does not exclude malignancy or bronchiectasis |
| Complete blood count | Assess for anemia, infection, thrombocytopenia | Hemoglobin (baseline and trend), white blood cell count, platelet count | Anemia suggests chronic blood loss or underlying disease; leukocytosis suggests infection |
| Coagulation studies (PT/INR, aPTT) | Identify coagulopathy; assess anticoagulation status | Prolonged PT/INR (warfarin, liver disease); prolonged aPTT (heparin, factor deficiency) | Essential before invasive procedures; guides need for reversal agents |
| Basic metabolic panel | Assess renal function (pulmonary-renal syndromes) | Elevated creatinine, blood urea nitrogen | Renal dysfunction with hemoptysis suggests vasculitis or Goodpasture syndrome |
| Urinalysis | Screen for glomerulonephritis | Hematuria (dysmorphic red blood cells), proteinuria, red blood cell casts | Hematuria with hemoptysis = pulmonary-renal syndrome until proven otherwise |
| Pulse oximetry | Assess oxygenation | Oxygen saturation less than 94% on room air | Low saturation indicates significant lung involvement or chronic disease; arterial blood gas if severely hypoxic |
| Sputum examination | Confirm true hemoptysis; identify infection | Gram stain, culture, acid-fast bacilli smear and culture, cytology | Cytology has low sensitivity for malignancy (approximately 20-30%); acid-fast bacilli essential in endemic areas or high-risk patients |
Key Principle: A normal chest radiograph does NOT exclude significant pathology. Up to 30% of patients with hemoptysis have a normal chest radiograph, including some with bronchiectasis, early lung cancer, and pulmonary embolism. CT chest is indicated when clinical suspicion is high despite normal radiograph, or for any patient with risk factors for malignancy.
Second-Line Investigations
Computed Tomography (CT) of the Chest
| CT Type | Indication | What It Shows | Practical Points |
|---|---|---|---|
| Standard CT chest with contrast | Suspected mass, lymphadenopathy, mediastinal pathology | Lung masses, mediastinal and hilar lymphadenopathy, pleural disease | Contrast helps characterize masses and identify vascular abnormalities |
| High-resolution CT (HRCT) | Suspected bronchiectasis or interstitial lung disease | Bronchiectasis (dilated airways, “signet ring” sign), interstitial patterns, small airways disease | Thin-slice protocol (1-2 mm); gold standard for bronchiectasis; no contrast needed |
| CT pulmonary angiography (CTPA) | Suspected pulmonary embolism | Filling defects in pulmonary arteries; pulmonary infarction | Requires IV contrast; contraindicated in severe renal impairment; also shows parenchymal disease |
| CT angiography of bronchial arteries | Localization before embolization; suspected vascular malformation | Bronchial artery hypertrophy, aneurysms, aberrant vessels, arteriovenous malformations | Useful for planning bronchial artery embolization; may identify non-bronchial systemic arterial supply |
Bronchoscopy
Indications
- Massive or life-threatening hemoptysis (emergent)
- Abnormal chest imaging requiring tissue diagnosis
- Localization of bleeding site
- Suspected endobronchial lesion
- Hemoptysis in high-risk patient (smoker over 40) with normal or non-diagnostic CT
- Recurrent hemoptysis without identified cause
- Therapeutic intervention (airway clearance, tamponade, endobronchial treatment)
Types and Uses
- Flexible bronchoscopy: Standard diagnostic procedure; can visualize to subsegmental bronchi; biopsy, brushings, bronchoalveolar lavage
- Rigid bronchoscopy: Emergent massive hemoptysis; provides larger working channel for suctioning and tamponade; better airway control
- Bronchoalveolar lavage: Serial lavage showing progressively bloodier return suggests diffuse alveolar hemorrhage; hemosiderin-laden macrophages confirm prior hemorrhage
Timing of Bronchoscopy
There is debate about optimal timing. Evidence suggests:
- Early bronchoscopy (within 48 hours): Higher yield for localizing active bleeding site (up to 90% versus 50% if delayed)
- After CT: Many experts recommend CT before bronchoscopy as it has higher diagnostic yield for peripheral lesions and bronchiectasis
- Emergent (immediate): Required for massive hemoptysis for localization, airway protection, and therapeutic intervention
- Combined approach: CT first (if patient stable) followed by bronchoscopy for tissue diagnosis or when CT is non-diagnostic
Targeted Investigations by Suspected Etiology
If Suspecting Lung Cancer
First-Line Tests
- CT chest with contrast: Characterize mass, assess for mediastinal invasion, lymphadenopathy, metastases
- Sputum cytology: Low sensitivity (20-30%) but if positive, provides diagnosis; obtain 3 early morning samples
- Bronchoscopy with biopsy: For central lesions; endobronchial ultrasound for lymph node sampling
Second-Line Tests
- CT-guided percutaneous biopsy: For peripheral lesions not accessible by bronchoscopy
- PET-CT: Staging; assess for distant metastases; evaluate indeterminate nodules
- Brain MRI: Staging for suspected or confirmed lung cancer
If Suspecting Pulmonary Embolism
First-Line Tests
- CT pulmonary angiography: Gold standard; sensitivity greater than 95% for main and lobar pulmonary embolism
- D-dimer: Useful to exclude PE in low-probability patients; if negative with low clinical probability, PE effectively ruled out
Second-Line Tests
- Lower extremity Doppler ultrasound: Identify deep vein thrombosis source; positive result confirms venous thromboembolism
- Ventilation-perfusion (V/Q) scan: Alternative when CT contraindicated (severe renal impairment, contrast allergy)
- Echocardiography: Assess for right heart strain; may visualize thrombus in transit
If Suspecting Tuberculosis
First-Line Tests
- Sputum acid-fast bacilli smear: Three early morning specimens; rapid result; sensitivity 50-80% for cavitary disease
- Sputum mycobacterial culture: Gold standard; takes 2-8 weeks; allows drug susceptibility testing
- GeneXpert MTB/RIF (nucleic acid amplification): Rapid diagnosis (within 2 hours); detects rifampin resistance
Second-Line Tests
- Interferon-gamma release assay or tuberculin skin test: Indicates prior exposure/latent infection; cannot distinguish latent from active disease
- Bronchoscopy with bronchoalveolar lavage: When sputum is negative or cannot be obtained
- CT chest: Characterize extent; identify cavities, tree-in-bud pattern, lymphadenopathy
If Suspecting Pulmonary-Renal Syndrome
First-Line Tests
- Antineutrophil cytoplasmic antibodies (ANCA): c-ANCA (anti-PR3) for granulomatosis with polyangiitis; p-ANCA (anti-MPO) for microscopic polyangiitis
- Anti-glomerular basement membrane antibodies: Diagnostic for Goodpasture syndrome (anti-GBM disease)
- Urinalysis with microscopy: Dysmorphic red blood cells, red cell casts indicate glomerulonephritis
Second-Line Tests
- Renal biopsy: Confirms glomerulonephritis; identifies linear IgG deposition (anti-GBM) versus pauci-immune (ANCA-associated)
- Bronchoscopy with bronchoalveolar lavage: Progressively hemorrhagic return confirms diffuse alveolar hemorrhage; hemosiderin-laden macrophages
- Complement levels (C3, C4): May be low in systemic lupus erythematosus
If Suspecting Bronchiectasis
First-Line Tests
- High-resolution CT chest: Gold standard; shows bronchial dilatation (internal diameter greater than adjacent pulmonary artery = “signet ring” sign), bronchial wall thickening, lack of tapering
- Sputum culture: Identify colonizing organisms (Pseudomonas aeruginosa, Haemophilus influenzae); guide antibiotic therapy
Second-Line Tests (Determine Etiology)
- Immunoglobulin levels: Screen for immunodeficiency
- Aspergillus serology and IgE: Allergic bronchopulmonary aspergillosis
- Sweat chloride or genetic testing: Cystic fibrosis (if young patient or suggestive features)
- Alpha-1 antitrypsin level: Associated with bronchiectasis and emphysema
If Suspecting Arteriovenous Malformation
First-Line Tests
- Contrast-enhanced CT chest: Identifies feeding artery and draining vein; characterizes lesion size and number
- Transthoracic contrast echocardiography (bubble study): Agitated saline injection; bubbles appearing in left atrium after 3-5 cardiac cycles indicates pulmonary arteriovenous shunt
Second-Line Tests
- Pulmonary angiography: Gold standard for detailed anatomy; performed immediately before embolization
- Genetic testing for hereditary hemorrhagic telangiectasia: ENG, ACVRL1, SMAD4 mutations
- Brain MRI: Screen for cerebral arteriovenous malformations in hereditary hemorrhagic telangiectasia
Investigation Algorithm by Clinical Scenario
| Clinical Scenario | Initial Investigations | If Initial Workup Negative |
|---|---|---|
| Mild hemoptysis, young non-smoker, recent upper respiratory infection | Chest radiograph; complete blood count; no further workup if history and radiograph consistent with acute bronchitis | Follow-up if symptoms persist beyond 1 week; CT if recurs |
| Any hemoptysis in smoker over age 40 | Chest radiograph → CT chest with contrast → bronchoscopy if CT abnormal or high clinical suspicion | Consider repeat CT in 3-6 months; smoking cessation |
| Recurrent hemoptysis with chronic productive cough | High-resolution CT (bronchiectasis protocol); sputum culture | Bronchoscopy; investigations for bronchiectasis etiology |
| Hemoptysis with pleuritic chest pain and dyspnea | CT pulmonary angiography (or V/Q scan if CT contraindicated); D-dimer if low probability | Consider other diagnoses (pneumonia, pleuritis); lower extremity Doppler |
| Hemoptysis with fever, weight loss, night sweats | Chest radiograph; sputum for acid-fast bacilli (smear, culture, GeneXpert); isolation precautions | CT chest; bronchoscopy with bronchoalveolar lavage |
| Massive hemoptysis (hemodynamically stable) | Secure airway; CT angiography (localization); urgent bronchoscopy | Bronchial artery embolization; surgical consultation |
| Massive hemoptysis (hemodynamically unstable) | Secure airway (consider intubation with double-lumen tube); rigid bronchoscopy; stabilize | Emergent bronchial artery embolization or surgery |
When to Refer to Specialist
- Pulmonology referral: Abnormal chest imaging, recurrent hemoptysis, hemoptysis requiring bronchoscopy, suspected bronchiectasis or interstitial lung disease
- Thoracic surgery referral: Suspected or confirmed lung cancer, massive hemoptysis not controlled by embolization, aspergilloma with significant symptoms
- Interventional radiology referral: Bronchial artery embolization for moderate-to-massive hemoptysis
- Rheumatology/Nephrology referral: Suspected vasculitis or pulmonary-renal syndrome
- Cardiology referral: Suspected mitral stenosis or other cardiac cause
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for hemoptysis
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Massive hemoptysis (greater than 100 mL/hour or greater than 600 mL/24 hours), respiratory distress, or hemodynamic instability | EMERGENT | Secure airway (consider intubation); position bleeding side down; IV access and resuscitation; emergent pulmonology/thoracic surgery consultation; prepare for bronchoscopy or embolization |
| Moderate hemoptysis (20-200 mL/day), stable vital signs but significant volume | URGENT | Hospital admission for observation; IV access; type and screen; CT chest; pulmonology consultation within 24 hours; close monitoring |
| Hemoptysis with concerning features (smoker over 40, weight loss, abnormal chest radiograph) | URGENT | Expedited outpatient CT chest within 1-2 weeks; pulmonology referral; do not delay workup |
| Mild hemoptysis (blood-streaked sputum) in low-risk patient with clear etiology (acute bronchitis) | ROUTINE | Chest radiograph; symptomatic treatment; safety-net advice to return if worsens or persists beyond 1 week |
| Suspected pulmonary embolism (pleuritic pain, dyspnea, risk factors) | EMERGENT | Oxygen supplementation; anticoagulation if high probability (unless contraindicated); CT pulmonary angiography urgently |
| Hemoptysis with hematuria and rising creatinine | EMERGENT | Suspect pulmonary-renal syndrome; urgent ANCA and anti-GBM antibodies; nephrology and pulmonology consultation; may need emergent immunosuppression or plasmapheresis |
Step 2: Classify by Volume
Mild (Less than 20 mL/day)
Blood-streaked sputum
Action: Proceed to Algorithm A (Outpatient Evaluation)
Moderate (20-200 mL/day)
Noticeable blood, patient concerned
Action: Proceed to Algorithm B (Urgent Evaluation)
Massive (Greater than 600 mL/day)
Life-threatening, risk of asphyxiation
Action: Proceed to Algorithm C (Emergent Management)
Step 3: Follow the Appropriate Algorithm
Algorithm A: Mild Hemoptysis (Outpatient Evaluation)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Young non-smoker with recent upper respiratory infection and blood-streaked sputum | Acute bronchitis | Chest radiograph; supportive care; follow-up in 1-2 weeks if not resolved |
| Patient over 40 with smoking history and any hemoptysis | Must exclude lung cancer | CT chest with contrast within 2 weeks; pulmonology referral if abnormal |
| Known bronchiectasis with mild increase in blood-streaked sputum | Bronchiectasis exacerbation | Sputum culture; antibiotics if infected; optimize airway clearance; CT if new or worsening |
| Mild hemoptysis with normal chest radiograph in low-risk patient | Likely bronchitis or upper airway source | ENT examination to exclude pseudohemoptysis; CT if persists beyond 2-4 weeks |
| Patient on anticoagulation with mild hemoptysis | Underlying lesion unmasked by anticoagulation | Check INR/coagulation; CT chest; continue anticoagulation unless severe; investigate underlying cause |
Algorithm B: Moderate Hemoptysis (Urgent Evaluation)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Moderate hemoptysis with fever, productive cough, consolidation | Pneumonia (possibly necrotizing or with abscess) | Hospital admission; CT chest; IV antibiotics; monitor for complications |
| Moderate hemoptysis in patient with known bronchiectasis | Bronchiectasis with bronchial artery bleeding | Admission for observation; CT if not recent; consider bronchial artery embolization if recurrent or worsening |
| Moderate hemoptysis with weight loss, night sweats, high-risk background | Tuberculosis or lung cancer | Isolation precautions; sputum AFB; CT chest; bronchoscopy; involve infectious disease and/or oncology |
| Moderate hemoptysis with sudden dyspnea and pleuritic pain | Pulmonary embolism with infarction | CTPA urgently; anticoagulation if confirmed; admission |
| Moderate hemoptysis with bilateral infiltrates and rising creatinine | Diffuse alveolar hemorrhage (vasculitis, Goodpasture syndrome) | ICU admission; urgent serologies (ANCA, anti-GBM); nephrology/rheumatology; prepare for immunosuppression |
Algorithm C: Massive Hemoptysis (Emergent Management)
Immediate Priorities in Massive Hemoptysis
Death from massive hemoptysis is usually due to asphyxiation, not exsanguination. Airway management is the first priority.
- Protect the airway: Position patient with bleeding side DOWN (if known) to prevent blood flooding the non-bleeding lung
- Supplemental oxygen: High-flow oxygen; prepare for intubation
- Intubation if needed: Large endotracheal tube (8.0 mm or larger) to allow bronchoscopy; consider selective main bronchus intubation of non-bleeding side or double-lumen tube
- IV access and resuscitation: Two large-bore IVs; type and crossmatch; correct coagulopathy
- Urgent consultation: Pulmonology, thoracic surgery, interventional radiology
- Localize and treat: Bronchoscopy (rigid preferred for massive hemoptysis) for visualization, suctioning, and tamponade; CT angiography to guide embolization
| Intervention | Description | When to Use |
|---|---|---|
| Bronchial artery embolization | Catheter-based occlusion of bleeding bronchial arteries using coils, particles, or glue | First-line intervention for massive hemoptysis once patient stabilized; success rate 70-90%; recurrence 10-30% |
| Endobronchial tamponade | Bronchoscopic placement of balloon catheter (Fogarty, Arndt blocker) to occlude bleeding bronchus | Temporizing measure to protect non-bleeding lung while arranging definitive treatment |
| Topical hemostatic agents | Cold saline lavage, topical epinephrine, tranexamic acid via bronchoscope | Adjunctive measures; may control minor bleeding or temporize |
| Surgical resection | Lobectomy or pneumonectomy to remove bleeding source | When embolization fails or not feasible; localized disease; adequate pulmonary reserve; mortality 20-40% in emergency setting |
Risk Stratification for Malignancy
| Risk Factor | Points | Clinical Application |
|---|---|---|
| Age greater than 40 years | +1 | Scoring: 0 points = Low risk (less than 2% malignancy) 1-2 points = Intermediate risk (5-15%) 3+ points = High risk (greater than 20%) Action: Low risk: Chest radiograph; CT if abnormal or symptoms persist Intermediate risk: CT chest within 2 weeks High risk: CT chest urgently; consider bronchoscopy |
| Smoking history (ever smoker) | +1 | |
| Duration greater than 1 week | +1 | |
| Abnormal chest radiograph | +2 | |
| Weight loss greater than 5% | +1 |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient coughs up large volume of blood in front of me | Keep calm; position bleeding side down (or lean forward); call for help; prepare suction; high-flow oxygen | Establish IV access; call for emergent airway support and specialist consultation |
| Patient on warfarin with hemoptysis and INR 4.5 | Hold warfarin; give vitamin K (IV if severe, oral if stable); consider prothrombin complex concentrate for massive bleeding | CT chest to identify source; investigate underlying cause; do not assume anticoagulation is the sole cause |
| CT shows a lung mass in patient with hemoptysis | Expedite tissue diagnosis (bronchoscopy, CT-guided biopsy, or surgical) | Staging workup; multidisciplinary discussion; pulmonology and oncology referral |
| CT and bronchoscopy are both normal in patient with recurrent hemoptysis | Consider cryptogenic hemoptysis; exclude pseudohemoptysis (ENT examination) | Reassure patient; smoking cessation; follow-up CT in 6-12 months; return precautions |
| Patient localizes bleeding to one side | Position that side DOWN to protect contralateral lung | Document for bronchoscopist; may guide selective intubation if needed |
| Hemoptysis resolves after acute bronchitis | Reassurance; no further workup needed if young, non-smoker, normal chest radiograph | Safety-net: return if recurs or any new concerning symptoms develop |
| Patient refuses hospital admission for moderate hemoptysis | Document discussion of risks including death from asphyxiation; ensure patient can call for help | Arrange urgent outpatient CT and specialist review; clear return instructions; consider involving family |
| Bronchial artery embolization performed but hemoptysis recurs | Repeat angiography (may have missed vessels or collateral recruitment) | Surgical consultation for possible resection if repeat embolization fails |
Troubleshooting Refractory Hemoptysis
Ask These Questions When Hemoptysis Persists
- Is the diagnosis correct? Consider alternative diagnoses; repeat or expand imaging
- Is this true hemoptysis? Re-examine for nasopharyngeal or gastrointestinal source (pseudohemoptysis)
- Are there multiple causes? Patients may have coexisting bronchiectasis AND malignancy
- Was embolization complete? Variant bronchial arteries or non-bronchial systemic arteries may have been missed
- Has collateral circulation developed? Common after embolization; may need repeat procedure
- Is the underlying disease progressing? Tumor growth, worsening infection, progression of bronchiectasis
- Is coagulopathy contributing? Check platelet count, PT/INR, aPTT; correct if abnormal
- Would surgery be appropriate? Consider in localized disease with adequate pulmonary reserve
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Asphyxiation kills before exsanguination: Death from massive hemoptysis is almost always due to drowning in blood, not bleeding to death. Airway protection is the first priority—position the patient with the bleeding side down to protect the non-bleeding lung.
Bronchial arteries cause most hemoptysis: Despite supplying only 1% of pulmonary blood flow, bronchial arteries (at systemic pressure) are the source of 90-95% of significant hemoptysis. In chronic lung disease, these vessels hypertrophy dramatically.
Normal chest radiograph does not exclude serious disease: Up to 30% of patients with hemoptysis have a normal chest radiograph, including some with bronchiectasis, early lung cancer, and pulmonary embolism. CT is indicated when clinical suspicion is high.
Always examine the nose and mouth: Pseudohemoptysis (blood from nasopharynx or oropharynx that is expectorated) accounts for up to 15% of patients presenting with apparent hemoptysis. A careful ENT examination can save unnecessary investigations.
Anticoagulants unmask underlying disease: Anticoagulation does not cause hemoptysis but prolongs bleeding from pre-existing lesions. Always investigate for an underlying cause—do not attribute hemoptysis solely to anticoagulation.
Hemoptysis plus hematuria equals emergency: The combination of hemoptysis and hematuria (or renal dysfunction) suggests pulmonary-renal syndrome (granulomatosis with polyangiitis or Goodpasture syndrome), which can progress rapidly without treatment. Urgent serologies and specialist consultation are essential.
Patient localization can be helpful: Ask if the patient can identify which side the blood is coming from. A sensation of warmth or gurgling on one side may help localize the bleeding and guide positioning, selective intubation, and bronchoscopy.
CT before bronchoscopy (usually): In stable patients, CT chest often provides more diagnostic information than bronchoscopy for peripheral lesions and bronchiectasis. However, early bronchoscopy (within 48 hours) has higher yield for localizing active bleeding.
Critical Pitfalls to Avoid
Dismissing hemoptysis in a smoker as “just bronchitis”: Any hemoptysis in a smoker over age 40 requires CT chest to exclude malignancy. Lung cancer is the cause in 10-20% of cases in this population, and early diagnosis improves survival.
Relying solely on volume to determine severity: A patient with severe chronic obstructive pulmonary disease may become critically ill from 100 mL of hemoptysis that would be well-tolerated by someone with normal lungs. Always consider the patient’s respiratory reserve.
Forgetting pulmonary embolism in the differential: Pulmonary embolism with infarction causes hemoptysis in approximately 30% of cases. Always consider PE when hemoptysis is accompanied by sudden dyspnea, pleuritic chest pain, or risk factors for venous thromboembolism.
Stopping anticoagulation reflexively: Mild hemoptysis often does not require stopping anticoagulation, especially if the indication is strong (mechanical valve, recent PE). Investigate the underlying cause and make a risk-benefit decision rather than reflexively holding the medication.
Missing Arnold’s nerve reflex: Stimulation of the external auditory canal (ear wax, foreign body) can trigger cough via Arnold’s nerve (a branch of the vagus). Always examine the ears in patients with unexplained chronic cough or hemoptysis.
Failing to isolate suspected tuberculosis: Hemoptysis with fever, night sweats, weight loss, and upper lobe infiltrates should prompt immediate respiratory isolation pending tuberculosis workup. Delayed isolation puts healthcare workers and other patients at risk.
Assuming normal examination excludes serious pathology: Physical examination is frequently normal in patients with lung cancer, bronchiectasis, pulmonary embolism, and other significant causes of hemoptysis. A normal examination should not provide false reassurance.
Delaying intervention for massive hemoptysis: Massive hemoptysis can progress to respiratory arrest within minutes. Immediate airway management, positioning, and activation of specialist support (pulmonology, interventional radiology, thoracic surgery) should not be delayed for imaging in an unstable patient.
Key Takeaways
- Hemoptysis ranges from trivial (blood-streaked sputum with bronchitis) to life-threatening (massive hemoptysis with asphyxiation risk). Classify by volume and assess respiratory reserve to determine urgency.
- The “Big Four” causes—bronchitis, bronchiectasis, lung cancer, and pneumonia—account for approximately 80% of cases. In tuberculosis-endemic areas, tuberculosis enters this list.
- Bronchial arteries (systemic pressure) are the source of most significant hemoptysis. In chronic lung disease, these vessels hypertrophy and become prone to rupture.
- Always differentiate true hemoptysis from pseudohemoptysis (nasopharyngeal or oral source) and hematemesis (gastrointestinal source). Examination of the nose, mouth, and oropharynx is essential.
- Any hemoptysis in a smoker over 40 years old requires CT chest to exclude lung cancer, regardless of chest radiograph findings.
- Hemoptysis with hematuria or renal dysfunction suggests pulmonary-renal syndrome—an emergency requiring urgent serologies and specialist involvement.
- Normal chest radiograph does not exclude serious disease. CT chest is indicated when clinical suspicion is high despite normal radiograph.
- For massive hemoptysis, remember that asphyxiation kills before exsanguination. Airway protection is the first priority—position bleeding side down and prepare for intubation.
- Bronchial artery embolization is the first-line intervention for massive hemoptysis with a 70-90% success rate. Surgical resection is reserved for embolization failure or when anatomy is favorable.
- Cryptogenic hemoptysis (no cause found despite thorough workup) has a good prognosis but requires follow-up imaging, as occult malignancy may be detected in up to 6% of cases within 3 years.
Quick Reference Algorithm
Systematic Approach to Hemoptysis:
- Assess stability: Airway, breathing, circulation. If massive hemoptysis or unstable, secure airway, position bleeding side down, and activate emergent support.
- Confirm true hemoptysis: Distinguish from pseudohemoptysis (nasopharyngeal/oral) and hematemesis (gastrointestinal). Examine nose, mouth, and oropharynx.
- Quantify and classify: Estimate volume (mild, moderate, massive) and duration (acute, subacute, chronic). Assess patient’s respiratory reserve.
- Take focused history: Use “BLOOD” mnemonic—Bleeding characteristics, Localizing symptoms, Other associated symptoms, Occupational/social/exposure history, Drug and medical history. Identify red flags.
- Perform systematic examination: General inspection, vital signs, ENT, neck (lymph nodes), respiratory, cardiovascular, extremities (clubbing, DVT signs).
- Order baseline investigations: Chest radiograph, complete blood count, coagulation studies, renal function, urinalysis, pulse oximetry, sputum studies.
- Risk-stratify and investigate further: CT chest for high-risk patients (smoker over 40, abnormal radiograph, recurrent hemoptysis). Consider CTPA if pulmonary embolism suspected. Bronchoscopy for tissue diagnosis or localization.
- Treat underlying cause: Antibiotics for infection, embolization for vascular bleeding, tumor-directed therapy for malignancy, immunosuppression for vasculitis.
- Arrange appropriate follow-up: Ensure safety-net advice; schedule repeat imaging for cryptogenic cases; refer to specialist as indicated.